We showed by RNA analysis that high expression of total collagens, LAIR-1, and combined high total collagen and high LAIR-1 are associated with a worse prognosis in multiple tumor types, supporting the notion of disrupting LAIR-1-collagen interactions as a novel immunotherapeutic strategy. The gene discussed is LAIR1; the disease is neoplasm.